2022
DOI: 10.1053/j.jvca.2021.11.005
|View full text |Cite
|
Sign up to set email alerts
|

Inhaled Pulmonary Vasodilator Utilization and Cost Following Initiation of a Protocol in a Quaternary Academic Heart Center Intensive Care Unit

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
3
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
5

Relationship

1
4

Authors

Journals

citations
Cited by 5 publications
(3 citation statements)
references
References 24 publications
0
3
0
Order By: Relevance
“…They are widely accepted for the treatment of perioperative RVF because of the temporary alterations in pulmonary vascular tone occurring during cardio-thoracic surgery (HT, LT, or LVAD implantation). Apart from the evidence of clinical similarity between iNO and iPGI2, the cost-saving difference remains a problem and is one of the main topics in the latest editorials and original articles [64,65].…”
Section: Discussionmentioning
confidence: 99%
“…They are widely accepted for the treatment of perioperative RVF because of the temporary alterations in pulmonary vascular tone occurring during cardio-thoracic surgery (HT, LT, or LVAD implantation). Apart from the evidence of clinical similarity between iNO and iPGI2, the cost-saving difference remains a problem and is one of the main topics in the latest editorials and original articles [64,65].…”
Section: Discussionmentioning
confidence: 99%
“…This is an important alternative therapy to inhaled nitric oxide for its cost benefit. A recent study by Austin et al 52 reported a projected annual savings of about $1,180,000 after implementing a protocol in the ICU that significantly reduced the use of inhaled nitric oxide and increased the use of iE. Second, this treatment may work in some patients and not in others due to the prolonged effect of milrinone persisting well after administration and its effect on both LV and RV dPdT and cardiac output in some patients.…”
Section: Anesthesia and Analgesiamentioning
confidence: 99%
“…Given that the majority of nurses and respiratory therapists in the United States are women and these providers spend the highest percentage of time in the room, this policy may have a huge impact on coverage and staffing models nationally. Inhaled epoprostenol is often preferred over nitric oxide as a pulmonary vasodilator given the cost difference in use and comparable efficacy and safety ( 21 , 22 ). The National Institute for Occupational Safety and Health is a U.S. Federal agency responsible for conducting research and making recommendations for the prevention of work-related injury and does not list epoprostenol as a risk to women who are actively trying to conceive, pregnant, or breastfeeding.…”
mentioning
confidence: 99%